01/29/2026
We're proud to share that Genomind has been awarded a contract by the U.S. Department of Defense to provide pharmacogenomics consulting in support of the Defense Health Agency.
This work will help guide the assessment and implementation of PGx within the Department of Defense Military Health System, with the goal of optimizing medication management and reducing adverse drug reactions and other health complications.
It’s an important step in advancing PGx and in supporting the health and readiness of those who serve.
https://www.businesswire.com/news/home/20260129933836/en/Department-of-Defense-Awards-Genomind-Contract-for-Pharmacogenomics-Consulting
#
Genomind awarded DoD contract to advance pharmacogenomics, embedding genetic insights into military health records to improve care and readiness.